JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
+6.79%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$115M
AUM Growth
+$115M
(+30%)
Cap. Flow
+$22M
Cap. Flow
% of AUM
19.16%
Top 10 Holdings %
Top 10 Hldgs %
83.38%
Holding
86
New
22
Increased
12
Reduced
15
Closed
31
Top Buys
| 1 |
PagSeguro Digital
PAGS
|
$16.6M |
| 2 |
AVP
Avon Products, Inc.
AVP
|
$10.5M |
| 3 |
Meta Platforms (Facebook)
META
|
$9.65M |
| 4 |
LINX
Linx S.A.
LINX
|
$5.84M |
| 5 |
Mercado Libre
MELI
|
$4.44M |
Top Sells
| 1 |
iShares MSCI Brazil ETF
EWZ
|
$24.6M |
| 2 |
Illumina
ILMN
|
$976K |
| 3 |
Sarepta Therapeutics
SRPT
|
$839K |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$741K |
| 5 |
BLUE
bluebird bio
BLUE
|
$569K |
Sector Composition
| 1 | Consumer Discretionary | 19.88% |
| 2 | Technology | 19.48% |
| 3 | Healthcare | 17.84% |
| 4 | Materials | 16.71% |
| 5 | Communication Services | 13.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Agilent Technologies
A
$35.7B
| $501K | 0.2% |
+6,704
| New | +$501K |
|
27
Acadia Pharmaceuticals
ACAD
$4.38B
| $473K | 0.19% |
17,697
+8,494
| +92% | +$227K |
|
28
HCA Healthcare
HCA
$94.5B
| $449K | 0.18% |
+3,320
| New | +$449K |
|
29
Eli Lilly
LLY
$657B
| $438K | 0.17% |
3,957
+1,049
| +36% | +$116K |
|
|
30
BioMarin Pharmaceuticals
BMRN
$11.2B
| $400K | 0.16% |
4,669
-8,650
| -65% | -$741K |
|
|
AMRN
31
Amarin Corp
AMRN
$311M
| $396K | 0.16% |
20,425
+9,401
| +85% | +$182K |
|
|
32
Sarepta Therapeutics
SRPT
$1.78B
| $365K | 0.14% |
2,399
-5,515
| -70% | -$839K |
|
|
ARRY
33
DELISTED
Array Biopharma Inc
ARRY
| $358K | 0.14% |
+7,724
| New | +$358K |
|
34
Ascendis Pharma
ASND
$11.8B
| $343K | 0.13% |
+2,981
| New | +$343K |
|
35
Merck
MRK
$210B
| $341K | 0.13% |
4,067
-1,141
| -22% | -$95.7K |
|
36
Centene
CNC
$14.3B
| $327K | 0.13% |
6,244
-2,950
| -32% | -$154K |
|
37
Regeneron Pharmaceuticals
REGN
$61.5B
| $311K | 0.12% |
993
+387
| +64% | +$121K |
|
38
AstraZeneca
AZN
$248B
| $307K | 0.12% |
+7,432
| New | +$307K |
|
39
Humana
HUM
$36.5B
| $297K | 0.12% |
1,119
-1,138
| -50% | -$302K |
|
40
Hologic
HOLX
$14.9B
| $285K | 0.11% |
+5,941
| New | +$285K |
|
|
WCG
41
DELISTED
Wellcare Health Plans, Inc.
WCG
| $267K | 0.11% |
+938
| New | +$267K |
|
42
Cooper Companies
COO
$13.4B
| $255K | 0.1% |
+758
| New | +$255K |
|
43
Neurocrine Biosciences
NBIX
$13.8B
| $248K | 0.1% |
2,934
-344
| -10% | -$29.1K |
|
44
argenx
ARGX
$43.6B
| $243K | 0.1% |
1,713
-575
| -25% | -$81.6K |
|
|
CELG
45
DELISTED
Celgene Corp
CELG
| $243K | 0.1% |
2,634
-2,395
| -48% | -$221K |
|
46
Amgen
AMGN
$155B
| $221K | 0.09% |
+1,201
| New | +$221K |
|
47
Teleflex
TFX
$5.59B
| $215K | 0.08% |
+650
| New | +$215K |
|
|
48
Illumina
ILMN
$15.8B
| $214K | 0.08% |
580
-2,644
| -82% | -$976K |
|
49
Exact Sciences
EXAS
$8.98B
| $201K | 0.08% |
1,703
-4,776
| -74% | -$564K |
|
|
OIBR
50
DELISTED
OI S A SPONSORED ADR REPSTG PFD NEW (BRA)
OIBR
| $11K | ﹤0.01% |
28,567
| – | – |
|